Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
303
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Samsung Biologics
•
26 Apr 2024 19:01
•
Broker
Samsung Biologics - Decent Earnings, Successful Contract Wins in Q1
1Q24 reports consolidated revenue of W946.9bn(+31% yoy), OP of W221.3bn (+15% yoy). Beat consensus owing to an increase in plant 4 operation rate...
Daishin Securities
Follow
336 Views
Share
bullish
•
Thematic (Sector/Industry)
•
21 Aug 2024 06:00
•
Broker
China Healthcare - Overseas CXO/ Life Science Upstream 2Q24 Review
We have summarized 2Q24 earnings of major overseas CXO and life science upstream (LSU) companies, which engage in clinical CROs, preclinical CROs,...
CMB International
Follow
156 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x